Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker IPSC
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Douglas Carr Officer | IPSC Century Therapeutics, Inc. | 266 | $404 | — | Nov 3, 2026 | Form 4 ↗ 2 days later · 266 shares | Form 144 ↗ |
| Sep 14, 2026 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 2,587 | $4,994 | — | Sep 14, 2026 | Form 4 ↗ 1 day later · 2,587 shares | Form 144 ↗ |
| Sep 14, 2026 | Douglas Carr Officer | IPSC Century Therapeutics, Inc. | 1,658 | $3,201 | — | Sep 14, 2026 | Form 4 ↗ 1 day later · 1,658 shares | Form 144 ↗ |
| Sep 8, 2026 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 534 | $1,094 | — | Sep 8, 2026 | Form 4 ↗ 1 day later · 534 shares | Form 144 ↗ |
| Jun 12, 2026 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 2,584 | $5,768 | — | Jun 12, 2026 | Form 4 ↗ 3 days later · 2,584 shares | Form 144 ↗ |
| Jun 8, 2026 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 524 | $1,106 | — | Jun 8, 2026 | Form 4 ↗ 1 day later · 524 shares | Form 144 ↗ |
| Mar 12, 2026 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 10,076 | $25.7K | — | Mar 12, 2026 | Form 4 ↗ 4 days later · 10,076 shares | Form 144 ↗ |
| Mar 9, 2026 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 479 | $1,215 | — | Mar 9, 2026 | Form 4 ↗ 2 days later · 479 shares | Form 144 ↗ |
| Dec 9, 2025 amended | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 0 | $0 | — | Dec 8, 2025 | — | Form 144/A ↗ |
| Dec 8, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 476 | $253 | — | Dec 8, 2025 | — | Form 144 ↗ |
| Dec 8, 2025 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 526 | $280 | — | Dec 8, 2025 | Form 4 ↗ 2 days later · 526 shares | Form 144 ↗ |
| Nov 20, 2025 | Chad Cowan Officer | IPSC Century Therapeutics, Inc. | 5,462 | $2,739 | — | Nov 20, 2025 | Form 4 ↗ 4 days later · 5,462 shares | Form 144 ↗ |
| Nov 17, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 32,456 | $14.7K | — | Nov 17, 2025 | Form 4 ↗ 2 days later · 32,456 shares | Form 144 ↗ |
| Sep 8, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 488 | $244 | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 488 shares | Form 144 ↗ |
| Sep 8, 2025 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 539 | $269 | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 539 shares | Form 144 ↗ |
| Aug 18, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 30,745 | $17.5K | — | Aug 18, 2025 | Form 4 ↗ 23 days later · 488 shares | Form 144 ↗ |
| Jun 9, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 475 | $296 | — | Jun 9, 2025 | Form 4 ↗ 2 days later · 475 shares | Form 144 ↗ |
| Jun 9, 2025 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 552 | $343 | — | Jun 9, 2025 | Form 4 ↗ 2 days later · 552 shares | Form 144 ↗ |
| Jun 9, 2025 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 526 | $327 | — | Jun 9, 2025 | Form 4 ↗ 2 days later · 526 shares | Form 144 ↗ |
| May 16, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 29,552 | $16.1K | — | May 16, 2025 | Form 4 ↗ 4 days later · 29,552 shares | Form 144 ↗ |
| May 5, 2025 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 1,024 | $563 | — | May 5, 2025 | Form 4 ↗ 2 days later · 1,024 shares | Form 144 ↗ |
| Mar 10, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 2,235 | $1,375 | — | Mar 10, 2025 | Form 4 ↗ 2 days later · 2,235 shares | Form 144 ↗ |
| Mar 10, 2025 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 2,360 | $1,452 | — | Mar 10, 2025 | Form 4 ↗ 2 days later · 2,360 shares | Form 144 ↗ |
| Mar 10, 2025 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 2,359 | $1,451 | — | Mar 10, 2025 | Form 4 ↗ 2 days later · 2,359 shares | Form 144 ↗ |
| Feb 18, 2025 | Brent Pfeiffenberger Officer, Director | IPSC Century Therapeutics, Inc. | 34,712 | $27.2K | — | Feb 18, 2025 | Form 4 ↗ 2 days later · 34,712 shares | Form 144 ↗ |
| Feb 3, 2025 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 1,054 | $823 | — | Feb 3, 2025 | Form 4 ↗ 2 days later · 1,054 shares | Form 144 ↗ |
| Nov 4, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 1,033 | $1,268 | — | Nov 4, 2024 | Form 4 ↗ 1 day later · 1,033 shares | Form 144 ↗ |
| Aug 5, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 1,073 | $1,960 | — | Aug 5, 2024 | — | Form 144 ↗ |
| Jul 26, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 586 | $1,465 | 10b5-1 | Jul 26, 2024 | — | Form 144 ↗ |
| Jul 24, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 1,600 | $4,030 | 10b5-1 | Jul 24, 2024 | — | Form 144 ↗ |
| Jul 23, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 200 | $500 | 10b5-1 | Jul 23, 2024 | — | Form 144 ↗ |
| Jun 20, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 5,000 | $14.2K | 10b5-1 | Jun 20, 2024 | — | Form 144 ↗ |
| Jun 5, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 5,000 | $15.0K | 10b5-1 | Jun 5, 2024 | — | Form 144 ↗ |
| May 20, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 5,000 | $15.2K | 10b5-1 | May 20, 2024 | — | Form 144 ↗ |
| May 6, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 5,000 | $15.6K | 10b5-1 | May 6, 2024 | — | Form 144 ↗ |
| May 3, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 913 | $2,836 | — | May 3, 2024 | — | Form 144 ↗ |
| Apr 22, 2024 | Gregory Russotti Officer | IPSC Century Therapeutics, Inc. | 5,000 | $15.5K | 10b5-1 | Apr 22, 2024 | — | Form 144 ↗ |
| Mar 20, 2024 | Diem Michael Craig Former Officer | IPSC Century Therapeutics, Inc. | 8,033 | $40.2K | — | Mar 20, 2024 | — | Form 144 ↗ |
| Mar 18, 2024 | Diem Michael Craig Former Officer | IPSC Century Therapeutics, Inc. | 2,725 | $13.6K | — | Mar 18, 2024 | — | Form 144 ↗ |
| Mar 15, 2024 | Diem Michael Craig Former Officer | IPSC Century Therapeutics, Inc. | 9,242 | $46.3K | — | Mar 15, 2024 | — | Form 144 ↗ |
| Mar 7, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 22,831 | $117.3K | 10b5-1 | Mar 7, 2024 | — | Form 144 ↗ |
| Mar 7, 2024 | Diem Michael Craig Former Officer | IPSC Century Therapeutics, Inc. | 986 | $5,120 | — | Mar 7, 2024 | — | Form 144 ↗ |
| Mar 6, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 30,684 | $152.3K | 10b5-1 | Mar 6, 2024 | — | Form 144 ↗ |
| Mar 6, 2024 | Diem Michael Craig Former Officer | IPSC Century Therapeutics, Inc. | 9,014 | $45.2K | — | Mar 6, 2024 | — | Form 144 ↗ |
| Feb 21, 2024 amended | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 485 | $2,358 | 10b5-1 | Feb 16, 2024 | — | Form 144/A ↗ |
| Feb 16, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 485 | $2,358 | 10b5-1 | Feb 16, 2024 | — | Form 144 ↗ |
| Feb 6, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 1,784 | $8,005 | — | Feb 6, 2024 | — | Form 144 ↗ |
| Feb 6, 2024 | Diem Michael Craig Officer | IPSC Century Therapeutics, Inc. | 2,011 | $9,024 | — | Feb 6, 2024 | — | Form 144 ↗ |
| Feb 5, 2024 | Farid Adrienne Officer | IPSC Century Therapeutics, Inc. | 2,035 | $7,816 | — | Feb 5, 2024 | — | Form 144 ↗ |
| Feb 5, 2024 | Diem Michael Craig Officer | IPSC Century Therapeutics, Inc. | 2,321 | $8,915 | — | Feb 5, 2024 | — | Form 144 ↗ |
50 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances